@article{4ccf038f52e34b9e9384f88c92bd2b5f,
title = "Validation of Cell-Cycle Arrest Biomarkers for Acute Kidney Injury Using Clinical Adjudication",
author = "Azra Bihorac and Chawla, \{Lakhmir S.\} and Shaw, \{Andrew D.\} and Ali Al-Khafaji and Davison, \{Danielle L.\} and DeMuth, \{George E.\} and Robert Fitzgerald and Gong, \{Michelle Ng\} and Graham, \{Derrel D.\} and Kyle Gunnerson and Michael Heung and Saeed Jortani and Eric Kleerup and Koyner, \{Jay L.\} and Kenneth Krell and Jennifer LeTourneau and Matthew Lissauer and James Miner and Nguyen, \{H. Bryant\} and Ortega, \{Luis M.\} and Self, \{Wesley H.\} and Richard Sellman and Jing Shi and Joely Straseski and Szalados, \{James E.\} and Wilber, \{Scott T.\} and Walker, \{Michael G.\} and Jason Wilson and Richard Wunderink and Zimmerman, \{Janice L.\} and Kellum, \{John A.\}",
note = "Rationale: We recently reported two novel biomarkers for acute kidney injury (AKI), tissue inhibitor of metalloproteinases (TIMP)-2 and insulin-like growth factor binding protein 7 (IGFBP7), both related to G1 cell cycle arrest. Objectives: We now validate a clinical test for urinary [TIMP-2]d [IGFBP7] at a high-sensitivity cutoff greater than 0.3 for AKI risk stratification in a diverse population of critically ill patients.",
year = "2014",
month = apr,
day = "15",
doi = "10.1164/RCCM.201401-0077OC",
language = "American English",
volume = "189",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1535-4970",
publisher = "American Thoracic Society",
number = "8",
}